Date: 2016-04-15
Type of information: Company acquisition
Acquired company: Crelux (Germany)
Acquiring company: WuXi AppTec (China)
Amount: undisclosed
Terms: * On April 15, 2015, WuXi AppTec announced that it has acquired Crelux GmbH, a leading structure based drug
discovery provider based in Munich, Germany. The acquisition represents a further step in the growing European presence of WuXi AppTec and reaffirms WuXi’s strong commitment to better serving and interacting with European customers. It provides a solid foundation for WuXi to expand its integrated drug discovery services within Europe.
Details: WuXi AppTec is a pharmaceutical, biotechnology, and medical device R&D platform company with global operations. The company provides a broad and integrated portfolio of laboratory and manufacturing services Crelux was founded in 2005 and has its laboratories at the Innovation Center for Biotechnology (IZB) in Martinsried. The company is a provider of high-quality solutions for early stage drug development and its core expertise lies in the production of prime proteins and their use in biophysical screening and protein crystallography. The addition of Crelux provides augmented scientific depth and complements existing capabilities within the WuXi structure-based drug discovery platform.
throughout the drug and medical device R&D process. WuXi AppTec is also building a platform to provide clinical diagnostic services directly to physicians and their patients globally.
Related: Technology - Services
